CASI icon

CASI Pharmaceuticals
CASI

Overview Fund Activity

32 hedge funds and large institutions have $2.56M invested in CASI Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Holders
32
Holders Change
+3
Holders Change %
+10.34%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$35K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$62K
3
MC
3
Moors & Cabot
Massachusetts
$102K
4
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$22K
5
WJA
5
Williams Jones & Associates
New York
$21K

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$0
2
UBS Group
2
UBS Group
Switzerland
$2K
3
BFA
3
BlackRock Fund Advisors
California
$42K
Name Market Value Shares Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
$0 80 – –
Creative Planning
27
Creative Planning
Kansas
$0 9 – –
FWM
28
Focused Wealth Management
New York
$0 45 – –
CPIG
29
Chicago Partners Investment Group
Illinois
$0 27 – –
NFG
30
Next Financial Group
Texas
$0 2 – –
SCM
31
Southport Capital Management
Tennessee
$0 19 +19 New
Deutsche Bank
32
Deutsche Bank
Germany
$0 21 +21 New
IA
33
IFP Advisors
Florida
$0 28 +28 New
AG
34
Advisor Group
Arizona
$0 130 +130 New
1
2